Literature DB >> 21106850

Akt contributes to activation of the TRIF-dependent signaling pathways of TLRs by interacting with TANK-binding kinase 1.

Sun Myung Joung1, Zee-Yong Park, Shilpa Rani, Osamu Takeuchi, Shizuo Akira, Joo Young Lee.   

Abstract

Toll/IL-1R domain-containing adaptor inducing IFN-β (TRIF) is an adaptor molecule that is recruited to TLR3 and -4 upon agonist stimulation and triggers activation of IFN regulatory factor 3 (IRF3) and expression of type 1 IFNs, which are critical for cellular antiviral responses. We show that Akt is a downstream molecule of TRIF/TANK-binding kinase 1 (TBK1) and plays an important role in the activation of IRF3 by TLR3 and -4 agonists. Blockade of Akt by a dominant-negative mutant or by short interfering RNA decreased IRF3 activation and IFN-β expression induced by polyinosinic:polycytidylic acid [poly(I:C)], LPS, TRIF, and TBK1. Association of endogenous TBK1 and Akt was observed in macrophages when stimulated with poly(I:C) and LPS. In vitro kinase assays combined with reversed-phase liquid chromatography mass spectrometry analysis showed that TBK1 enhanced phosphorylation of Akt on Ser(473), whereas knockdown of TBK1 expression by short interfering RNA in macrophages decreased poly(I:C)- and LPS-induced Akt phosphorylation. Embryonic fibroblasts derived from TBK1 knockout mice also showed impaired Akt phosphorylation in response to poly(I:C) and LPS. To our knowledge, our results demonstrate a new regulatory mechanism for Akt activation mediated by TBK1 and a novel role of Akt in TLR-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21106850     DOI: 10.4049/jimmunol.0903534

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

Review 1.  PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

2.  Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury.

Authors:  Ling-Juan Zhang; George L Sen; Nicole L Ward; Andrew Johnston; Kimberly Chun; Yifang Chen; Christopher Adase; James A Sanford; Nina Gao; Melanie Chensee; Emi Sato; Yi Fritz; Jaymie Baliwag; Michael R Williams; Tissa Hata; Richard L Gallo
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

3.  Phosphatidylinositol-3-kinase and Akt are required for RIG-I-mediated anti-viral signalling through cross-talk with IPS-1.

Authors:  Sang Hyeon Yeon; Moon Jung Song; Hye-Ri Kang; Joo Young Lee
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

4.  Beneficial innate signaling interference for antibacterial responses by a Toll-like receptor-mediated enhancement of the MKP-IRF3 axis.

Authors:  Hideo Negishi; Kosuke Matsuki; Nobuyasu Endo; Hana Sarashina; Shoji Miki; Atsushi Matsuda; Keiko Fukazawa; Naoko Taguchi-Atarashi; Hiroaki Ikushima; Hideyuki Yanai; Junko Nishio; Kenya Honda; Yoichiro Fujioka; Yusuke Ohba; Tetsuo Noda; Shun'ichiro Taniguchi; Eisuke Nishida; Yongliang Zhang; Hongbo Chi; Richard A Flavell; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

5.  STING Requires the Adaptor TRIF to Trigger Innate Immune Responses to Microbial Infection.

Authors:  Xin Wang; Tanmay Majumdar; Patricia Kessler; Evgeny Ozhegov; Ying Zhang; Saurabh Chattopadhyay; Sailen Barik; Ganes C Sen
Journal:  Cell Host Microbe       Date:  2016-09-14       Impact factor: 21.023

6.  AKT goes cycling.

Authors:  Kiran N Mahajan; Nupam P Mahajan
Journal:  Cancer Control       Date:  2014-07       Impact factor: 3.302

7.  TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer.

Authors:  Jonathan M Cooper; Yi-Hung Ou; Elizabeth A McMillan; Rachel M Vaden; Aubhishek Zaman; Brian O Bodemann; Gurbani Makkar; Bruce A Posner; Michael A White
Journal:  Cancer Res       Date:  2017-07-17       Impact factor: 12.701

Review 8.  Mammalian TOR signaling to the AGC kinases.

Authors:  Bing Su; Estela Jacinto
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-10-10       Impact factor: 8.250

9.  The Akt1 isoform is required for optimal IFN-β transcription through direct phosphorylation of β-catenin.

Authors:  Benjamin N Gantner; Huali Jin; Feng Qian; Nissim Hay; Bin He; Richard D Ye
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

10.  Suppression of Toll-like receptor 4 activation by endogenous oxidized phosphatidylcholine, KOdiA-PC by inhibiting LPS binding to MD2.

Authors:  Min Jin Kim; Na Young Choi; Jung Eun Koo; So Young Kim; Sun Myung Joung; Eunshil Jeong; Joo Young Lee
Journal:  Inflamm Res       Date:  2013-03-09       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.